Form 4: Evolent Health President's Equity Transactions

Evolent Health's President, Daniel Joseph McCarthy, reported significant equity transactions including the settlement of performance-based share units and a new large PSU grant.

Summary

• Daniel Joseph McCarthy, President of Evolent Health, Inc. (EVH), reported multiple transactions involving Class A Common Stock and performance-based share units (PSUs).
• McCarthy acquired 39,281 shares of Class A Common Stock on March 2, 2026, resulting from the settlement of PSUs awarded on March 1, 2024, after the Compensation Committee certified the achievement of specified performance metrics.
• Shares were withheld to satisfy tax withholding obligations for both restricted stock units (RSUs) and performance-based share units (PSUs), totaling 7,811 shares at $3.25, 18,192 shares at $3.58, and 24,027 shares at $3.51.
• A new grant of 826,440 performance-based share units (PSUs) was awarded to Mr. McCarthy on March 2, 2026, with potential earning based on stock price performance from March 1, 2027, to February 28, 2029.
• The actual amount earned from the new PSU grant can range from 0% to 250% of the target level, contingent on satisfying certain service-based conditions.
• Following these transactions, McCarthy's direct beneficial ownership of Class A Common Stock is 423,022 shares, in addition to 826,440 derivative PSUs.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive filing. While there are tax-related dispositions, the significant new PSU grant and the settlement of previous PSUs based on achieved performance metrics indicate strong alignment of executive incentives with shareholder value and past company success.

Positives

• The settlement of 39,281 performance-based share units indicates the achievement of prior performance metrics by the company, reflecting past operational success.
• The grant of 826,440 new performance-based share units aligns management's incentives directly with future stock price appreciation and long-term company performance.
• The new PSU grant's potential payout ranging up to 250% of target provides a strong incentive for outperformance and sustained value creation.

Negatives

• A total of 50,030 shares were disposed of to cover tax withholding obligations, which, while common, represents a reduction in direct share ownership.

Future Outlook

The newly granted 826,440 performance-based share units for Mr. McCarthy are tied to the achievement of certain stock price performance conditions over a period from March 1, 2027, to February 28, 2029, indicating a future focus on share value growth. The potential payout ranges from 0% to 250% of the target level, subject to service-based conditions.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance-based equity awards, such as PSUs, is a common practice in the healthcare technology sector. This structure aims to align the interests of executives with long-term shareholder value creation, a trend observed across growth-oriented companies in the industry.

Stakeholder Impact

• Shareholders: The new PSU grant aligns the President's interests with future stock price performance, potentially benefiting shareholders if performance targets are met. The settlement of previous PSUs indicates past performance achievements.
• Employees: The compensation structure reflects the company's approach to executive incentives, which can influence broader compensation philosophies.

Next Steps

• Achievement of stock price performance conditions for the newly granted PSUs between March 1, 2027, and February 28, 2029.
• Continued satisfaction of service-based conditions by Mr. McCarthy for the new PSU grant.

Key Dates

Recommendation

The filing details routine executive compensation activities, including the vesting of prior performance awards and the grant of new performance-based units. While the new PSU grant aligns management incentives with future stock performance, these transactions do not provide new fundamental information to warrant a change in investment thesis. The tax-related dispositions are standard practice. Therefore, a 'hold' recommendation is appropriate as the filing does not present a compelling reason to alter an existing position.

Keywords

Evolent Health, EVH, Form 4, Insider Trading, Performance Share Units, PSUs, Restricted Stock Units, RSUs, Executive Compensation, Stock Transactions, Daniel Joseph McCarthy